New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measuresDUBLIN and FLORENCE, Italy, March 9, 2024 /PRNewswire/ -- Medtronic plc. (NYSE: MDT), a global leader in healthcare technology, today shared a robust set of new clinical and real-world evidence on the MiniMed™ 780G system from around the world including the largest set of data from early users in the United States. The data was presented at the 17th Internatio ...

Board authorizes $5 billion for share repurchases DUBLIN, March 7, 2024  /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 7, 2024, approved the company's cash dividend for the fourth quarter of fiscal year 2024 of $0.69 per ordinary share. This quarterly declaration is consistent with the dividend announcement made by the company in May 2023.  Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past ...

Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate statistically significant reductions in systolic blood pressure, intra-cardiac volumes, total peripheral resistance and stroke work, with no significant changes in stroke volume or contractility. AVIM therapy showed consistent favorable hemodynamic effects using both conduction system pacing, as well as traditional rig ...

Rising tides don't always lift all boats. The S&P 500 index reached new all-time highs several times since 2024 began, but many of its components have not participated in the rally.With most investors focusing all their attention on the artificial intelligence (AI) revolution, plenty of reliable dividend payers aren't getting the attention they deserve. Since peaking in 2021, shares of Medtronic (MDT 1.75%) are down about 38% and poised for a rebound. Altria Group (MO -2.77%) and Realty Income (O 0.90%) hit ...

This photo taken on Nov. 8, 2023 shows a booth of Medtronic at the 6th China International Import ... [+] Expo CIIE in east China's Shanghai. (Photo by Wang Xiang/Xinhua via Getty Images)Xinhua News Agency via Getty ImagesMedtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and adjusted earnings of $1.30 per share compared to the consensus estimates of $7.9 billion ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 26, 2024 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of incorporation) (I.R ...

8.9 mmHg mean reduction in 24-Hour ambulatory systolic blood pressure at average of 3.6 years from initiation of AVIM therapy in patients who participated in the MODERATO II study Orchestra BioMed is actively enrolling patients in the BACKBEAT pivotal study of AVIM therapy in hypertensive pacemaker patients NEW HOPE, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company"))), a biomedical company accelerating high-impact technologies to patie ...

Bloomberg/Bloomberg via Getty Images Thesis In my previous article about Medtronic plc (NYSE:MDT), released in I assigned a fair price of $137.6 which at the time indicated a 71.82% upside. The reason for this targets was because I updated my models following Q2 2024 released in November 30, 2023, and I explained how weight loss drugs will not affect Medtronic. This last one drove me to upgrade Medtronic from "buy" to "strong buy". So far, my thesis has materialized, since Medtronic reported Q3 2024 and it ...

(Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesDeal Overview On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient Monitoring and Respiratory Intervention (PMRI) Business mainly on improved performance in Patient Monitoring business. Currently Medtronic business consist Cardiovascular Portfolio, Medic ...

Medtronic (MDT 0.06%) is a leading medical device company that aims to simplify patients' everyday lives. And with a broad presence that spans 150 countries, treating more than 70 health conditions, Medtronic has the potential to be a great healthcare investment to buy and hold.Unfortunately, the company has battled multiple headwinds in recent times, which has led to uninspiring financials and a disappointing stock performance. In the past three years, shares of Medtronic have fallen by 24%. Can the next t ...